Anticancer agent 183 exhibits anticancer activity by inhibiting matrix metalloproteinase-9 (MMP-9) activity by more than 75% at a concentration of 100 μg/mL; it shows potent cytotoxicity against A549 cells with an IC50 value of <0.14 μM; and it induces apoptosis.